85 / 132
Schedules
forming part of the accounts
SCHEDULE 16 NOTES FORMING PART OF THE ACCOUNTS
(contd)
11 Segment information
(a) Information about business segment - primary
(
`
crores)
Particulars
Life Science
Chemicals
Performance &
Other Chemicals
Total
2010-11 2009-10 2010-11 2009-10 2010-11 2009-10
1 Segment revenues
External sales
530.26 401.69 1063.99 824.27 1594.25 1225.96
Inter segment sales
–
–
38.15 34.97 38.15 34.97
Total segment revenues
530.26 401.69 1102.14 859.24 1632.40 1260.93
Less: Inter segment revenues
–
–
38.15 34.97 38.15 34.97
Net revenues from operations
530.26 401.69 1063.99 824.27 1594.25 1225.96
2 Segment results
Profit before interest and tax
90.01 66.27 73.41 50.19 163.42 116.46
Interest
25.46 25.69
Other unallocable expenditure
(1.32)
11.02
(net of unallocable income)
Profit before tax
139.28 79.75
3 Other information
Segment assets
268.34 241.29 671.58 607.86 939.92 849.15
Unallocated common assets
307.00 272.51
Total assets
1246.92 1121.66
Segment liabilities
74.80 70.85 190.63 160.82 265.43 231.67
Unallocated common liabilities
63.11 88.02
Total liabilities
328.54 319.69
Capital expenditure
6.16 2.17 39.20 15.93 45.36 18.10
Unallocated capital expenditure
1.53 2.58
Total capital expenditure
46.89 20.68
Depreciation
9.05 9.17 27.01 26.07 36.07 35.24
Unallocated depreciation
2.47 2.06
Total depreciation
38.54 37.30
Significant non cash expenses
–
–
–
–
–
–
Significant unallocated non cash expenses
–
–
Total significant non cash expenses
–
–
82 | 83